Brown Seaweed Lipids as Potential Source of Omega-3 PUFA in Biological Systems

Handbook of Marine Macroalgae: Biotechnology and Applied Phycology

Volumn , Issue , 2011, Pages 329-339

  Miyashita, Kazuo ^a   Narayan, Bhaskar ^b   Tsukui, Takayuki ^a   Kamogawa, Hiroyuki ^a   Abe, Masayuki ^a,c   Hosokawa, Masashi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b CENTRAL FOOD TECHNOLOGICAL RESEARCH INSTITUTE   (India)

^c KANEKA CORPORATION   (Japan)

Author keywords

Algae, and fatty acid; Brown seaweed lipids; EPA, DHA in marine lipids; Humans, safe DHA supplementation; LN to DHA bioconversion; Omega 3 PUFA, biological systems; Polyunsaturated fatty acids; PUFA for humans

Indexed keywords

EID: 84886005762     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781119977087.ch16     Document Type: Chapter

References (113)

1. Albert, C.M., Campos, H., Stampfer, M.J., et al. (2002) Blood levels of long-chain n-3 fatty acids and the risk of sudden death.N. Engl. J. Med., 346, 1113-1118.
2. Allayee, H., Roth, N. and Hodis, H.N. (2009) Polyunsaturated fatty acids and cardiovascular disease: implications for nutrigenetics. J. Nutrigenet. Nutrigenomics, 2, 140-148.
3. Anderson, B.M. and Ma, D.W.L. (2009) Are all n-3 polyunsaturated fatty acids created equal? Lipids Health Dis., 8, 33.
4. Arao, T. and Yamada M. (1989) Positional distribution of fatty acids in galactolipids of algae. Phytochemistry, 28, 805-810.
5. Barre D.E. (2007) The role of consumption of alphalinolenic, eicosapentaenoic and docosahexaenoic acids in human metabolic syndrome and type 2 diabetes-a mini-review. J. Oleo Sci., 56, 319-325.
6. Belkind-Gerson, J., Carre ón-Rodríguez, A., Contreras-Ochoa, C.O., Estrada-Mondaca, S. and Parra-Cabrera M.S. (2008) Fatty acids and neurodevelopment J. Pediatr. Gastroentrol., Nutr. 47, S7-S9.
7. Bhaskar, N., Tomohisa, K.,Miyashita, K., Park, S.-B., Endo, Y. and Fujimoto, K. (2004a) Occurrence of conjugated polyenoic fatty acids in seaweeds from the Indian Ocean. Z. Naturforsch., 59C, 310-314.
8. Bhaskar, N.,Hosokawa,M.andMiyashita, K. (2004b)Comparitive evaluation of fatty acid composition of different Sargassum (Fucales, Phaeophyta) species harvested from temperate and tropical waters. J. Aquatic Product Tech., 13, 53-70.
9. Bhaskar, N., Hosokawa, M. and Miyashita, K. (2004c) Growth inhibition of human pro-myelocytic leukemia (9HL-60) cells by lipid extracts of marine alga Sargassam marginatum (Fucales, Phaeophyta) harvested off Goa (west coast of India) with special reference to fatty acid composition. Indian J. Marine Sci., 33, 355-360.
10. Bhaskar, N. andMiyashita, K. (2005) Lipid composition of Padina tetrastomatica (Dictyotalea, Phaeophyta), brown seaweed of the west coast of India. Indian J. Fish., 52, 263-268.
11. Blond, J.P., Clouet, P., Bezard, J. and Legendre, C. (1989) Effect of fenofibrate treatment on linoleic acid desaturation in liver of obese Zucker rats. Biochem. Pharmacol., 38, 2741-2744.
12. Brenna, J.T., Salem Jr., N., Sinclair, A.J. and Cunnane, S.C. (2009) a-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot. Essent. Fatty Acids, 80, 85-91.
13. Burgess, J.R., De la Rosa, R.I., Jacobs, R.S. and Butler, A. (1991) A new eicosapentonoic acid formed from Arachidonic acid in the coralline red algae Bassiella orbigniana. Lipids, 26, 162-165.
14. Calder, P.C. (2004) n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin. Sci., 107, 1-11.
15. Calder, P.C. (2006) N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases.Am. J. Clin.Nutr., 83, 1505S-1519S.
16. Childs, C.E., Romeu-Nadal, M., Burdge, G.C. and Calder, P.C. (2008) Gender differences in the n-3 fatty acid content of tissues. Proc. Nutr. Soc., 67, 19-27.
17. Cho, H.P., Nakamura, M. and Clarke, S.D. (1999) Cloning, expression, and nutritional regulation of the mammalian delta-6 desaturase. J. Biol. Chem., 274, 471-477.
18. Conn, P.F., Schalch,W. andTruscott,T.G. (1991) The singlet oxygen and carotenoid interaction. J. Photochem. Photobiol. B., 11, 41-47.
19. Das, S.K., Ren R., Hashimoto, T. and Kanazawa, K. (2010) Fucoxanthin induces apoptosis in osteoclast-like cells differentiated from RAW 264.7 cells. J. Agric. Food Chem., 58, 6090-6095.
20. Davidson, M. (2006) Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am. J. Cardiol., 98, 27i-33i.
21. Daviglus, M.L., Stamler, J., Orencia, A.J., et al. (1997) Fish consumption and the 30-year risk of fatal myocardial infarction. N. Engl. J. Med., 336, 1046-1053.
22. De Backer, G., Ambrosioni, E., Borch-Johnsen, K., et al. (2003) European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur. Heart J., 24, 1601-1610.
23. Dembitsky, V.M. and Maoka, T. (2007) Allenic and cumulenic lipids. Prog. Lipid Res., 46, 328-375.
24. Gazi, I.F., Tsimihodimos, V., Tselepis, A.D., Moses Elisaf, M. and Mikhailidis, D.P. (2007) Clinical importance and therapeutic modulation of small dense lowdensity lipoprotein particles. Expert. Opin. Biol. Ther., 7, 53-72.
25. Gebauer, S., Harris, W. S., Kris-Etherton, P. M. and Etherton, T. D. (2004) Dietary n-6:n-3 fatty acid ratio and health. In: Healthful Lipids (eds. Akoh, C.C. and Lai, O.-M). AOCS Press, Champaign, Illinois, pp. 221-248.
26. Givens, D.I. and Gibbs, R.A. (2008) Current intakes of EPA and DHA in European populations and the potential of animal-derived foods to increase them. Proc. Nutr. Soc., 67, 273-280.
27. Goyens, P.L., Spilker, M.E., Zock, P.L., Katan, M.B. and Mensink, R.P. (2005) Compartmental modeling to quantify alpha-linolenic acid conversion after longer term intake of multiple tracer boluses. J. Lipid. Res., 46, 1474-1483.
28. Guisto, N.M., Salvador, G.A., Castagnet, P.I., Pasquare, S.J. and Ilincheta de Bschero, M.G. (2002) Age-associated changes in central nervous system glycerophospholipids composition and metabolism.Neurochem. Res., 27, 1513-1523.
29. Hamazaki, T. and Okuyama, H. (2003) The Japan society for lipid nutrition recommends to reduce the intake of linoleic acid. A review and critique of the scientific evidence. World Rev. Nutr. Diet., 92, 109-132.
30. Harris, W. and Bulchandani, D. (2006) Why do omega-3 fatty acids lower serumtriglycerides? Curr.Opin. Lipidol., 17, 387-393.
31. Harris, W.S., Miller, M., Tighe, A.P., Davidson, M.H. and Schaefer, E.J. (2008) Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis, 197, 12-24.
32. Harwood, J.L. and Jones, A.L. (1989) Lipid metabolism in algae. Adv. Bot. Res., 16, 1-53.
33. Heo, S.-J., Yoon, W.-J., Kim, K.-N., et al. (2010) Evaluation of anti-inflammatory effect of fucoxanthin isolated from brown algae in lipopolysaccharide-stimulated RAW264.7 macrophages. Food Chem. Toxicol., 48, 2045-2051.
34. Hoffman, D.R., Boettcher, J.A. and Diersen-Schade, D.A. (2009) Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: A review of randomized controlled trials. Prostaglandins Leukotr. Essent. Fatty Acids, 81, 151-158.
35. Hokanson, J.E. and Austin, M.A. (1996) Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J. Cardiovasc. Risk, 3, 213-219.
36. Hosokawa, M., Miyashita, T., Nishikawa, S., et al. (2010) Fucoxanthin regulates adipocytokine mRNA expression in white adipose tissue of diabetic/obese KK-Ay mice. Arch. Biochem. Biophys., 504, 17-25.
37. Hosokawa, M., Okada, T., Mikami, N., Konishi, I. and Miyashita, K. (2009) Bio-functions of marine carotenoids. Food Sci. Biotech., 18(1), 1-11.
38. Hussein, N., Ah-Sing, E., Wilkinson, P., et al. (2005) Long-chain conversion of [13C] linoleic acid and alphalinolenic acid in response to marked changes in their dietary intake in men. J. Lipid Res., 46, 269-280.
39. Infante, J.P. and Huszagh, V.A. (1998) Analysis of the putative role of 24-carbon polyunsaturated fatty acids in the biosynthesis of docosapentaenoic (22:5n-6) and docosahexaenoic (22;6n-3) acids. FEBS Lett., 431, 1-6.
40. Innis, S.M. (2003) Perinatal biochemistry and physiology of long chain polyunsaturated fatty acids. J. Pediatr., 143, S1-S8.
41. Innis S.M. (2008) Dietary omega 3 fatty acids and the developing brain. Brain Res., 1237, 35-43.
42. Innis, S.M. (2009) Omega-3 fatty acids and neural development to 2 years of age: do we know enough for dietary recommendations? ., 48, S16-S24.
43. Innis, S.M. and Jacobson, K. (2007) Dietary lipids in early development and intestinal inflammatory disease. Nutr. Rev., 65, 5188-5189.
44. Jump,D.B. (2002) The biochemistry of n-3 polyunsaturated fatty acids. J. Biol. Chem., 277, 8755-8758.
45. Jump, D. (2004) Fatty acid regulation of gene transcription. Crit. Rev. Clin. Lab. Sci., 41, 41-78.
46. Kamenarska, Z., Funda N. Yalçin, F.D., Ersöz, T., ç aliş, İ., Stefanova, K. and Popova, S. (2002) Chemical composition of Cystoseira crinita bory from the eastern Mediterranean. Z. Naturfosch., 57c, 584-590.
47. Kaneniwa, M., Itabashi, Y. and Takagai, T. (1987) Unusual 5-olefinic acids in the lipids of algae from Japanese water. Bull. Jap. Soc. Sci. Fish., 53, 861-866.
48. Kayama, M., Araki, S. and Sato, S. (1989) Lipids of marine plants. In: Marine Biogenic Lipids, Fats and Oils, Vol. II (eds Ackman, R.G). CRC Press Inc., Boca Raton, FL, pp. 3-48.
49. Kayama, M., Iijima, N., Kuwahara, M., Sado, T., Araki, S. and Sakurai, T. (1985) Effect of water temperature on the fatty acid composition of Porphyra. Bull. Jpn. Soc. Sci. Fish., 51, 687.
50. Kawashima, Y., Musoh, K. and Kozuka, H. (1990) Peroxisome proliferators enhance linoleic acid metabolism in rat liver. Increased biosynthesis of omega 6 polyunsaturated fatty acids. J. Biol. Chem., 265, 9170-9175.
51. Kelley, D.S., Siegel, D., Vemuri, M. andMackey, B.E. (2007) Docosahexaenoic acid supplementation improves fasting and postprandial lipid profiles in hypertriglyceridemic men. Am. J. Clin. Nutr., 86, 324-333.
52. Khotimchenko, S.V. (1991) Fatty acid composition of seven Sargassum species. Phytochemistry, 30, 2639-2641.
53. Khotimchenko, S.V. and Svetashev,V.I. (1987) Fatty acids of marine macrophytes. Biol. Morya (Vladivostok), 6, 3-15.
54. Kim, K.-N., Heo, S.-J., Kang, S.-M., Ahn, G. and Jeon, Y.J. (2010a) Fucoxanthin induces apoptosis in human leukemia HL-60 cells through a ROS-mediated Bcl-xL pathway. Toxicol. In Vitro, 24, 1648-1654.
55. Kim, K.N., Heo, S.-J., Yoon, W.-J., et al. (2010b) Fucoxanthin inhibits the inflammatory response by suppressing the activation of NF-ΚB and MAPKs in lipopolysaccharide-induced RAW 264.7 macrophages. Eur. J. Pharmacol., 649, 369-375.
56. Kris-Etherton, P.M.,Harris,W.S. andAppel, L.J. (2002) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation, 106, 2747-2757.
57. Kris-Etherton, P.M., Taylor, D.S., Yu-Poth, S., et al. (2000) Polyunsaturated fatty acids in the food chain in the United States. Am. J. Clin.Nutr., 71, S179-S188.
58. Lands, W.E.M. (2005) Fish, Omega-3 and Human Health, 2nd edn. AOCS Press, Champaign, IL, USA, pp. 3-160.
59. Le, H.D.,Meisel, J.A., deMeijer,V.E.,Gura, K.M. and Puder, M. (2009) The essentiality of arachidonic acid and docosahexaenoic acid. Prostaglandins Leukotr. Essent. Fatty Acids, 81, 165-170.
60. Leaf, A., Kang, J.X. and Xiao, Y.-F. (2008) Fish oil fatty acids as cardiovascular drugs. Curr. Vasc. Pharmacol., 6, 1-12.
61. Li,D. and Bode,O.,Drummond, H. and Sinclair, A.J. (2003) Omega-3 (n-3) fatty acids. In: Lipids for Functional Foods and Nutraceuticals (ed. Gunstone, F.D.) The Oily Press, Bridgwater, UK, pp. 225-262.
62. Li, X., Fan, X., Han, L. and Lou, Q. (2002) Fatty acids of some algae from the Bohai Sea. Phytochemistry, 59, 157-161.
63. Liu, C.-L. Yung-Sheng Huang, Y.-S., Hosokawa, M., Miyashita, K. andHu, M.-L. (2009) Inhibition of proliferation of a hepatoma cell line by fucoxanthin in relation to cell cycle arrest and enhanced gap junctional intercellular communication. Chem. Biol. Int., 182, 165-172.
64. Maeda, H., Hosokawa, M., Sashima, T., Funayama, K. and Miyashita, K. (2005) Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissues. Biochem. Biophys. Res. Commun., 332, 392-397.
65. Maeda, H., Hosokawa, M., Sashima, T., Funayama, K. and Miyashita, K. (2007a) Effect of medium-chain triacylglycerols on anti-obesity effect of fucoxanthin. J. Oleo Sci., 56, 615-621.
66. Maeda, H., Hosokawa, M., Sashima, T. and Miyashita, K. (2007b) Dietary combination of fucoxanthin and fish oil attenuates the weight gain of white adipose tissue and decrease blood glucose in obese/diabetic KK-Ay mice. J. Agric. Food Chem., 55, 7701-7706.
67. Maeda, H., Hosokawa, M., Sashima, T., Murakami-Funayama, K. andMiyashita, K. (2009) Anti-obesity and anti-diabetic effects of fucoxanthin on diet-induced obesity conditions in a murine model. Mol. Med. Rep., 2, 897-902.
68. Marquardt, J. and Hanelt, D. (2004). Carotenoid composition of Delesseria lancifolia and other marine red algae from polar and temperate habitats. Eur. J. Phycol., 39, 285-292.
69. Matsuno, T. (2001) Aquatic animal carotenoids. Fish. Sci., 67, 771-783.
70. Miller, N.J., Sampson, J., Candeias, L.P., Bramley, P.M. and Rice-Evans, C.A. (1996) Antioxidant activities of carotenes and xanthophylls. FEBS Lett., 384, 240-242.
71. Miyashita, K. (2009) The carotenoid fucoxanthin from brown seaweed affects obesity. Lipid Tech., 21, 186-190.
72. Miyashita, K. and Hosokawa, M. (2009) Anti-obesity effect of allenic carotenoid, fucoxanthin. In: Nutrigenomics and Proteomics in Health and Disease: Impact of Food Factors-Gene Interactions (edsMine, Y.,Miyashita, K. and Shahidi, F.). John Wiley & Sons, Inc., Ames, IA, USA. pp. 145-160.
73. Miyashita, K.,Maeda, H., Okada,T.,Abe,M.andHosokawa, M. (2010)Anti-obesity and anti-diabetic effects of allenic carotenoid, fucoxanthin. AgroFOOD, 21, 24-27.
74. Mori, T.A. and Beilin, L.J. (2004) Omega-3 fatty acids and inflammation. Curr. Atheroscler. Rep., 6, 461-467.
75. Mozaffarian, D., Lemaitre, R.N., Kuller, L.H., Burke, G.L., Tracy, R.P. and Siscovick, D.S. (2003) Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the CardiovascularHealth Study. Circulation, 107, 1372-1377.
76. Narayan, B.,Miyashita, K. and Hosokawa, M. (2004) Comparative evaluation of fatty acid composition of different Sargassum (Fucales, Phaephyta) species harvested from temperate and tropical waters. J. Aqua. Food Product Tech., 13, 53-70.
77. Narayan, B.,Miyashita, K. and Hosokawa, M. (2006) Physiological effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)-a review. Food Rev. Int., 22, 291-307.
78. Narayan, B., Kumar, C.S., Sashima, T., Maeda, H., Hosokawa, M. and Miyashita, K. (2008) Composition, functionality and potential applications of seaweed lipids. In: Biocatalysis and Bioenergy (ed. Ho, C.T.). John Wiley & Sons, Inc., New York, pp. 463-490.
79. Nishino, H. (1998) Cancer prevention by carotenoids. Mutat. Res., 402, 159-163.
80. Nishino, H., Murakoshi, M. Tokuda, H. and Satomi, Y. (2009) Cancer prevention by carotenoids. Arch. Biochem. Biophys., 483, 165-168.
81. Nomura, T., Kikuchi, M., Kubodera, A. and Kawakami, Y. (1997) Proton-donative antioxidant activity of fucoxanthin with 1,1-diphenyl-2-picrylhydrazyl (DPPH). Biochem. Mol. Biol. Int., 42, 361-370.
82. Novak, E., Dyer, R.A. and Innis, S.M. 2008. High dietary omega-6 fatty acids contribute to reduced docosahexaenoic acid in the developing brain and inhibit secondary neurite growth. Brain Res., 1237, 136-145.
83. Prabhasankar, P., Ganesan, P., Bhaskar, N., et al. (2009) Edible Japanese seaweed, Wakame (Undaria pinnatifida) as an ingredient in pasta: chemical, functional and structural evaluation. Food Chem., 115, 501-508.
84. Rodriguez, A., Sarda, P., Boulot, P., Leger, C.L. and Descomps, B. (1999) Differential effect of N-ethyl maleimide on delta 6 desaturase activity in human fetal liver toward fatty acids of the n-6 and n-3 series. Lipids, 34, 23-30.
85. Russo, G.L. (2010) Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascularprevention. Biochem. Pharmacol., 235, 785-795.
86. Sachindra, N.M., Sato, E., Maeda, H., et al. (2007). Radical scavenging and singlet oxygen quenching activity of marine carotenoid fucoxanthin and its metabolites. J. Agric. Food Chem., 55, 8516-8522.
87. Sampath, H. and Ntambi, J. (2004) Polyunsaturated fatty acid regulation of gene expression. Nutr. Rev., 62, 333-339.
88. Sanchez-Machado, D.I., Lopez-Cervantes, J., Lopez-Hernandez, J. and Paseiro-Losada, P. (2004a) Fatty acids, total lipid, protein and ash contents of processed edible seaweeds. Food Chem., 85, 439-444.
89. Sanchez-Machado, D.I., Lopez-Hernandez, P., Paseiro-Losada, P. and Lopez-Cervantes. (2004b) An HPLC method for the quantification of sterols in edible seaweeds. Biomed. Chromatogr., 18, 183-190.
90. Sanders, T.A. (2000) Polyunsaturated fatty acids in the food chain in Europe. Am. J. Clin. Nutr., 71, 176S-178S.
91. Satoh, N., Shimatsu, A., Kotani, K., et al. (2007) Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome. Diabetes Care, 30, 144-146.
92. Satomi, Y. and Nishino, H. (2009) Implication of mitogenactivated protein kinase in the induction of G1 cell cycle arrest and gadd45 expression by the carotenoid fucoxanthin in human cancer cells. Biochim. Biophys. Acta, 1790, 260-266.
93. Schubert, N., García-Mendoza, E. and Pacheco-Ruiz, I. (2006) Carotenoid composition of marine red algae. J. Phycol., 42, 1208-1216.
94. Shahidi, F. andMiraliakbari, H. (2006)Marine oils: compositional characteristics and health effects. In: Nutraceutical and Specialty Lipids and Their Co-Products (ed. Shahidi, F.). CRC Press, New York, USA, pp. 227-250.
95. Shiratori, K., Ohgami, K., Ilieva, I., et al. (2005) Effects of fucoxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Exp. Eye Res., 81, 422-428.
96. Simpoulous, A.P. (1999) Essential fatty acids in health and chronic disease. Am. J. Clin. Nutr., 70, 560-595.
97. Simopoulos, A.P. (2008) The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp. Biol. Med., 233, 674-688.
98. Simopoulos, A.P. (2010) Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk. Exp. Biol. Med., 235, 785-795.
99. Sinclair, A., Wallace, J., Martin, M., Attar-Bashi, N., Weisinger, R. and Li, D. (2005) The effects of eicosapentaenoic acid in various clinical condirions. In: Healthful Lipids (eds Akoh, C.C. and Lai, O.-M.). AOCS Press, Champaign, IL, USA, pp. 361-394.
100. Smith Jr, S.C., Allen, J., Blair, S.N., et al. (2006) AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by theNationalHeart, Lung, and Blood Institute. Circulation, 113, 2363-2372.
101. Sprecher, H. (1981) Biochemistry of essential fatty acids. Prog. Lipid Res., 20, 13-22.
102. Stefanov, K., Konaklieva, M., Brechany, E.Y. and Christie, W.W. (1988) Fatty acid composition of some algae from the Black sea. Phytochemistry, 27, 3495-3497.
103. Terasaki, M., Hirose, A., Narayan, B., et al. (2009) Evaluation of recoverable functional lipid components with special reference to fucoxanthin and fucosterol contents of several brown seaweeds of Japan. J. Phycol., 45, 974-980.
104. Tziomalos, K., Athyros, V.G., Karagiannis, A. and Mikhailidis, D.P. (2008) Omega-3 fatty acids: how can they be used in secondary prevention? Curr. Atherosclerosis Rep., 10, 510-517.
105. Tsukui, T., Konno, K., Hosokawa, M., Maeda, H., Sashima, T. andMiyashita, K. (2007) Fucoxanthin and fucoxanthinol enhance the amount of docosahexaenoic acid in the liver of KKAy obese/diabetic mice. J. Agric. Food Chem., 55, 5025-5029.
106. Tsukui, T., Baba, T., Hosokawa, M., Sashima, T. and Miyashita, K. (2009) Enhancement of hepatic docosahexaenoic acid and arachidonic acid contents in C57BL/6J mice by dietary fucoxanthin. Fish. Sci., 75, 261-263.
107. Vaskovsky, V.E., Khotimchenko, S.V., Xia, B. and Hefang, L. (1996) polar lipids and fatty acid of some marine macrophytes from the Yellow Sea. Phytochemistry, 42, 1347-1356.
108. Vila, L. (2004) Cyclooxygenase and 5-lipoxygenase pathways in the vessel wall: role in atherosclerosis. Med. Res. Rev., 24, 399-424.
109. Wang, C., Harris,W.S., Chung,M., et al. (2006) Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primaryand secondary prevention studies: a systematic review. Am. J. Clin. Nutr., 84, 5-17.
110. Watkins, S.M., Reifsnyder, P.R., Pan, H.J., German, J.B. and Leiter, E.H. (2002) Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone. J. Lipid Res., 43, 1809-1817.
111. Wise, M.L., Hamberg, M. and Gerwick, W.H. (1994) Biosythesis of conjugated triene containing fatty acids by novel isomerase from the red marine alga Ptilota filicina. Biochemistry, 33, 15231-15232.
112. Yan, X., Chuda, Y., Suzuki, M. and Nagata, T. (1999) Fucoxanthin as the major antioxidant in Hijikia fusiformis, a common edible seaweed. Biosci. Biotechnol. Biochem., 63, 605-607.
113. Zhou, D., Ghebremeskel, K., Crawford, M.A. and Reifen, R. (2006) Vitamin A deficiency enhances docosahexaenoic and osbond acids in liver of rats fed an R-linolenic acidadequate diet. Lipids, 41, 213-219.